Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Remon, J., Besse, B., Aix, S. Ponce, Callejo, A., Al-Rabi, K., Bernabe, R., Greillier, L., Majem, M., Reguart, N., Monnet, I., Cousin, S., Garrido, P., Robinet, G., Garcia Campelo, R., Madroszyk, A., Mazières, J., Curcio, H., Wasąg, B., Pretzenbacher, Y., Fournier, B., Dingemans, A.-M.C., Dziadziuszko, R.
Published in Annals of oncology (01.05.2023)
Published in Annals of oncology (01.05.2023)
Get full text
Journal Article
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
Besse, B., Felip, E., Garcia Campelo, R., Cobo, M., Mascaux, C., Madroszyk, A., Cappuzzo, F., Hilgers, W., Romano, G., Denis, F., Viteri, S., Debieuvre, D., Galetta, D., Baldini, E., Razaq, M., Robinet, G., Maio, M., Delmonte, A., Roch, B., Masson, P., Schuette, W., Zer, A., Remon, J., Costantini, D., Vasseur, B., Dziadziuszko, R., Giaccone, G., Zemanová, M., Besse, B., Bonnet, C., Cadranel, J., Chouaid, C., Cortot, A., Debieuvre, D., Delclaux, B., Denis, F., Duchemann, B., El Kouri, C., Ferrand, F.R., Ginoux, M., Hilgers, W., Madroszyk, A., Masson, P., Mazieres, J., Molinier, O., Moro-Sibilot, D., Pichon, E., Mascaux, C., Robinet, G., Roch, B., Zalcman, G., Schmidtke-Schrezenmeier, G., Schuette, W., Urban, L., Gottfried, M., Nechushtan, H., Peled, N., Wollner, M., Zer, A., Baldini, E., Bonanno, L., Bonetti, A., Cappuzzo, F., Delmonte, A., Galetta, D., Maio, M., Minotti, V., Rea, A., Romano, G., Tassinari, D., Tonini, G., Dziadziuszko, R., Karaszewska, B., Szczęsna, A., Cobo, M., De Castro, J., Felip, E., Garcia Campelo, M.R., Hernández, A., Moran, T., Provencio, M., Viteri, S., Dasgupta, A., Gabrail, N., Giaccone, G., Harshad, A., Liu, S., Oubre, D., Panikkar, R., Razaq, M., Sanborn, R.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
3128 EGFR, ALK, KRAS prognostic value in a large French prospective cohort of non-previously treated advanced NSCLC. Preliminary report of the IFCT-PREDICT.amm cohort
Cadranel, J, Quoix, E, Duruisseaux, M, Friard, S, Fabre, E, Daniel, C, Westeel, V, Madroszyk, A, Lena, H, Merle, P, Mazieres, J, Dansin, E, Scherpereel, A, Hiret, S, Coudert, B, Souquet, P.J, Missy, P, Morin, F, Zalcman, G, Barlesi, F
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Chemotherapy (platinum and pemetrexed) in combination with erlotinib in non‐small cell lung cancer induces major gastrointestinal toxicity: two case reports from the FLARE/GFPC 03‐2013 study
Sassier, M., Peyro‐Saint‐Paul, L., Clarisse, B., Leconte, A., Coquerel, A., Alexandre, J., Fedrizzi, S., Leroy‐Terquem, E., Madroszyk, A., Gervais, R.
Published in Journal of clinical pharmacy and therapeutics (01.08.2016)
Published in Journal of clinical pharmacy and therapeutics (01.08.2016)
Get full text
Journal Article
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer
Guardiola, E., Peyrade, F., Chaigneau, L., Cupissol, D., Tchiknavorian, X., Bompas, E., Madroszyk, A., Ronchin, P., Schneider, M., Bleuze, J.P., Blay, J.Y., Pivot, X.
Published in European journal of cancer (1990) (01.09.2004)
Published in European journal of cancer (1990) (01.09.2004)
Get full text
Journal Article
High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party
DE GIORGI, U, BLAISE, D, LANGE, A, VIENS, P, MARANGOLO, M, MADROSZYK, A, BRUNE, M, AFANASSIEV, B. V, ROSTI, G, DEMIRER, T
Published in Bone marrow transplantation (Basingstoke) (01.12.2007)
Published in Bone marrow transplantation (Basingstoke) (01.12.2007)
Get full text
Journal Article
214 POSTER AP5346 (ProLindacTM), a pH-dependent polymer-vectorized DACH platinum, is active in borderline potentially platinum-sensitive ovarian cancer (OC) patients: results from an ongoing Phase I/II trial
Joly, F, Madroszyk, A, Floquet, A, Gedouin, D, Bourdel, F, Campone, M
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Analyse rétrospective monocentrique des résultats de la chirurgie pour compression médullaire métastatique : taux de survie, facteurs pronostiques et efficacité clinique
Fuentes, S, Tabouret, E, Cauvin, C, Esterni, B, Adetchessi, T, Madroszyk, A, Gonçalves, A, Casalonga, F, Brunelle, S, Salem, N, Gonzague, L, Tarpin, C, Gravis, G
Published in Neuro-chirurgie (01.12.2012)
Published in Neuro-chirurgie (01.12.2012)
Get full text
Journal Article
1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial
Giaccone, G., Felip, E., Cobo, M., Campelo, R. Garcia, DENIS, F., Quoix, E., Madroszyk, A., Debieuvre, D., Hilgers, W., Moran, T., Galetta, D., Romano, G.D., Cappuzzo, F., Robinet, G., Masson, P., Viteri, S., Peled, N., Costantini, D., Dziadziuszko, R., Besse, B.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
LBA47 Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial
Besse, B., Garcia Campelo, M.R., Cobo Dols, M.A., Quoix, E., Madroszyk, A., Felip, E., Cappuzzo, F., Denis, F., Hilgers, W., Romano, G., Debieuvre, D., Baldini, E., Galetta, D., Viteri, S., Phan, M., Schuette, W., Zer, A., Costantini, D., Dziadziuszko, R., Giaccone, G.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)
Girard, N., Mazieres, J., Otto, J., Lena, H., Lepage, C., Egenod, T., Smith, D., Madelaine, J., Gérinière, L., El Hajbi, F., Ferru, A., Clément-Duchêne, C., Madroszyk, A., Desrame, J., Morin, F., Langlais, A., Michel, P., Louvet, C., Westeel, V., Walter, T.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
P1.04-33 Deep Phenotyping of Immune Populations Reveals Baseline Predictors of Pembrolizumab Efficacy in NSCLC on KEYNOTE-001
Rochigneux, P., Lisberg, A., Garcia, A., Chretien, A.S., Fattori, S., Madroszyk, A., Tseng, A., Akingbemi, W., Gukasyan, J., Madrigal, J., Carroll, J., Noor, Z., Cummings, A., Olive, D., Garon, E.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
1354PA SCORE TO GUIDE THE DECISION FOR RETREATMENT AFTER 2 LINES OF SYSTEMIC PALLIATIVE THERAPY FOR SOLID TUMORS. A PROSPECTIVE STUDY
Chanez, B., Gilabert, M., Madroszyk, A., Rousseau, F., Perrot, D., Bertucci, F., Viens, P., Raoul, J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
A Score to Guide the Decision for Retreatment After 2 Lines of Systemic Palliative Therapy for Solid Tumors. a Prospective Study
Chanez, B., Gilabert, M., Madroszyk, A., Rousseau, F., Perrot, D., Bertucci, F., Viens, P., Raoul, J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
P2.15-29 Eligibility for Anti-Angiogenic Treatments in Patients with Squamous Non-Small Cell Lung Cancer (SQ-NSCLC): EPISQUAMAB Study (GFPC 2015-01)
Vergnenegre, A., Basse, V., Le Garff, G., Bylicki, O., Dubos-Arvis, C., Comet, B., Marcq, M., Le Treut, J., Auliac, J.B., Madroszyk, A., Fraboulet, G., Crequit, J., Thomas, P., Paleiron, N., Monnet, I.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
P3.03-27 Somatic BRCA1/2 Mutations in Advanced NSCLC Patients: Description of a Sub-Population from the Ongoing Unicancer SAFIR02-Lung / IFCT-1301 Trial
Remon, J., Rouleau, E., Barlesi, F., Leary, A., Bièche, I., Job, B., Lacroix, L., Auguste, A., Mauduit, M., Audigier-Valette, C., Raimbourg, J., Madroszyk, A., Michiels, S., Bayar, M.A., Jimenez, M., Soria, J., Besse, B.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
OA15.02 Carboplatin-Etoposide Versus Topotecan as Second-Line Treatment for Sensitive Relapsed Small-Cell Lung Cancer: Phase 3 Trial
Baize, N., Monnet, I., Greillier, L., Geier, M., Lena, H., Janicot, H., Vergnenegre, A., Crequit, J., Lamy, R., Auliac, J.B., Le Treut, J., Le Caer, H., Gervais, R., Dansin, E., Madroszyk, A., Renault, P., Legarff, G., Schott, R., Saulnier, P., Chouaid, C.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
SIOG2021-0077 - Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer (AM-NSCLC)
Cabart, M., Mourey, L., Girard, N., Otto, J., Gervais, R., Madroszyk, A., Chouaid, C., Dubray-Longeras, P., Pérol, M., Hiret, S., Kaderbhai, C., Pichon, E., Debieuvre, D., Baranzelli, A., Schneider, S., Schott, R., Pasquier, D., Simon, G., Martin, A.L., Cabarrou, B.
Published in Journal of geriatric oncology (01.12.2021)
Published in Journal of geriatric oncology (01.12.2021)
Get full text
Journal Article